Details for Australian Trade Mark No. 1376938 (hide)

Owner Celgene Corporation

IR Number 1044823

Filing Date 29 June 2010

Classes

Class 42 Conducting clinical trials; conducting clinical trials on the safety and effectiveness of apremilast; conducting clinical trials on the safety and effectiveness of a drug for psoriasis, rheumatoid arthritis and cancer; conducting clinical trials on the safety and effectiveness of a drug directed to prostate-specific antigen

Event Publications

26 August 2010 Application filed

28 October 2010 Application Accepted

17 February 2011 Trade Mark Registered/Protected

26 May 2011 Cancellation of Entrie in Register

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1376939-VIVON

1376937